These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 36735955

  • 1. Microbial Dynamics in Newly Diagnosed and Treatment Naïve IBD Patients in the Mediterranean.
    Rausch P, Ellul S, Pisani A, Bang C, Tabone T, Marantidis Cordina C, Zahra G, Franke A, Ellul P.
    Inflamm Bowel Dis; 2023 Jul 05; 29(7):1118-1132. PubMed ID: 36735955
    [Abstract] [Full Text] [Related]

  • 2. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients.
    Čipčić Paljetak H, Barešić A, Panek M, Perić M, Matijašić M, Lojkić I, Barišić A, Vranešić Bender D, Ljubas Kelečić D, Brinar M, Kalauz M, Miličević M, Grgić D, Turk N, Karas I, Čuković-Čavka S, Krznarić Ž, Verbanac D.
    Gut Microbes; 2022 Jul 05; 14(1):2083419. PubMed ID: 35695669
    [Abstract] [Full Text] [Related]

  • 3. Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission.
    Pisani A, Rausch P, Bang C, Ellul S, Tabone T, Marantidis Cordina C, Zahra G, Franke A, Ellul P.
    Microbiol Spectr; 2022 Jun 29; 10(3):e0061622. PubMed ID: 35532243
    [Abstract] [Full Text] [Related]

  • 4. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.
    Kabeerdoss J, Jayakanthan P, Pugazhendhi S, Ramakrishna BS.
    Indian J Med Res; 2015 Jul 29; 142(1):23-32. PubMed ID: 26261163
    [Abstract] [Full Text] [Related]

  • 5. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
    Ma HQ, Yu TT, Zhao XJ, Zhang Y, Zhang HJ.
    World J Gastroenterol; 2018 Apr 07; 24(13):1464-1477. PubMed ID: 29632427
    [Abstract] [Full Text] [Related]

  • 6. Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders.
    Teofani A, Marafini I, Laudisi F, Pietrucci D, Salvatori S, Unida V, Biocca S, Monteleone G, Desideri A.
    Nutrients; 2022 Jan 08; 14(2):. PubMed ID: 35057440
    [Abstract] [Full Text] [Related]

  • 7. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.
    Nishino K, Nishida A, Inoue R, Kawada Y, Ohno M, Sakai S, Inatomi O, Bamba S, Sugimoto M, Kawahara M, Naito Y, Andoh A.
    J Gastroenterol; 2018 Jan 08; 53(1):95-106. PubMed ID: 28852861
    [Abstract] [Full Text] [Related]

  • 8. 16S sequencing and functional analysis of the fecal microbiome during treatment of newly diagnosed pediatric inflammatory bowel disease.
    Ashton JJ, Colquhoun CM, Cleary DW, Coelho T, Haggarty R, Mulder I, Batra A, Afzal NA, Beattie RM, Scott KP, Ennis S.
    Medicine (Baltimore); 2017 Jun 08; 96(26):e7347. PubMed ID: 28658154
    [Abstract] [Full Text] [Related]

  • 9. Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn's Disease.
    Liu B, Ye D, Yang H, Song J, Sun X, Mao Y, He Z.
    Front Immunol; 2022 Jun 08; 13():921546. PubMed ID: 35860271
    [Abstract] [Full Text] [Related]

  • 10. Gut microbiota analyses of inflammatory bowel diseases from a representative Saudi population.
    Alsulaiman RM, Al-Quorain AA, Al-Muhanna FA, Piotrowski S, Kurdi EA, Vatte C, Alquorain AA, Alfaraj NH, Alrezuk AM, Robinson F, Dowdell AK, Alamri TA, Hamilton L, Lad H, Gao H, Gandla D, Keating BJ, Meng R, Piening B, Al-Ali AK.
    BMC Gastroenterol; 2023 Jul 28; 23(1):258. PubMed ID: 37507685
    [Abstract] [Full Text] [Related]

  • 11. A microbial signature for Crohn's disease.
    Pascal V, Pozuelo M, Borruel N, Casellas F, Campos D, Santiago A, Martinez X, Varela E, Sarrabayrouse G, Machiels K, Vermeire S, Sokol H, Guarner F, Manichanh C.
    Gut; 2017 May 28; 66(5):813-822. PubMed ID: 28179361
    [Abstract] [Full Text] [Related]

  • 12. Dysbiotic signatures and diagnostic potential of gut microbial markers for inflammatory bowel disease in Korean population.
    Kim HS, Oh SJ, Kim BK, Kim JE, Kim BH, Park YK, Yang BG, Lee JY, Bae JW, Lee CK.
    Sci Rep; 2024 Oct 10; 14(1):23701. PubMed ID: 39390011
    [Abstract] [Full Text] [Related]

  • 13. Enteric Virome and Bacterial Microbiota in Children With Ulcerative Colitis and Crohn Disease.
    Fernandes MA, Verstraete SG, Phan TG, Deng X, Stekol E, LaMere B, Lynch SV, Heyman MB, Delwart E.
    J Pediatr Gastroenterol Nutr; 2019 Jan 10; 68(1):30-36. PubMed ID: 30169455
    [Abstract] [Full Text] [Related]

  • 14. Dynamic immunoglobulin responses to gut bacteria during inflammatory bowel disease.
    Rengarajan S, Vivio EE, Parkes M, Peterson DA, Roberson EDO, Newberry RD, Ciorba MA, Hsieh CS.
    Gut Microbes; 2020 May 03; 11(3):405-420. PubMed ID: 31203722
    [Abstract] [Full Text] [Related]

  • 15. Characterization of fungal dysbiosis in Japanese patients with inflammatory bowel disease.
    Imai T, Inoue R, Kawada Y, Morita Y, Inatomi O, Nishida A, Bamba S, Kawahara M, Andoh A.
    J Gastroenterol; 2019 Feb 03; 54(2):149-159. PubMed ID: 30478724
    [Abstract] [Full Text] [Related]

  • 16. Adolescent gut microbiome imbalance and its association with immune response in inflammatory bowel diseases and obesity.
    Joo M, Nam S.
    BMC Microbiol; 2024 Jul 19; 24(1):268. PubMed ID: 39030520
    [Abstract] [Full Text] [Related]

  • 17. Seasonal variations in gut microbiota and disease course in patients with inflammatory bowel disease.
    Tani M, Shinzaki S, Asakura A, Tashiro T, Amano T, Otake-Kasamoto Y, Yoshihara T, Yoshii S, Tsujii Y, Hayashi Y, Inoue T, Motooka D, Nakamura S, Iijima H, Takehara T.
    PLoS One; 2023 Jul 19; 18(4):e0283880. PubMed ID: 37071621
    [Abstract] [Full Text] [Related]

  • 18. Taxonomic and phenotypic analysis of bifidobacteria isolated from IBD patients as potential probiotic strains.
    Bosselaar S, Dhelin L, Dautel E, Titecat M, Duthoy S, Stelmaszczyk M, Delory N, De Sousa Violante M, Machuron F, Ait-Abderrahim H, Desreumaux P, Foligné B, Monnet C.
    BMC Microbiol; 2024 Jun 29; 24(1):233. PubMed ID: 38951788
    [Abstract] [Full Text] [Related]

  • 19. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
    Imhann F, Vich Vila A, Bonder MJ, Fu J, Gevers D, Visschedijk MC, Spekhorst LM, Alberts R, Franke L, van Dullemen HM, Ter Steege RWF, Huttenhower C, Dijkstra G, Xavier RJ, Festen EAM, Wijmenga C, Zhernakova A, Weersma RK.
    Gut; 2018 Jan 29; 67(1):108-119. PubMed ID: 27802154
    [Abstract] [Full Text] [Related]

  • 20. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
    Abdelbary MMH, Hatting M, Bott A, Dahlhausen A, Keller D, Trautwein C, Conrads G.
    Front Cell Infect Microbiol; 2022 Jan 29; 12():1010853. PubMed ID: 36275026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.